AMP issue illustrates the pressure on Rx

February 8, 2016 by Jeffrey Woldt and Chain Drug Review Affordable Care Act, AMP, average manufacturer prices, Centers for Medicare & Medicaid Services, CMS, Covered Outpatient Drugs, federal upper limits, FULs, Jeffrey Woldt, Medicaid, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, pharmacy reimbursement, Steve Anderson 2016, Issue 02-08-2016, Issues, Leading Headlines, Opinion

After years of political and legal wrangling, the Centers for Medicare & Medicaid Services (CMS) has issued its final rule on Covered Outpatient Drugs, which governs reimbursement to retail pharmacies for generic medications dispensed under Medicaid. The history of the regulation goes all the way back to the Deficit Reduction Act of 2005 (DRA), which